Evidence supports that ICAM1 binds to MUC1, which is known to be overexpressed in cancer cells and cancer stem cells, and CD80 binds to CTLA4, which is an immunosuppressive marker that is also expressed in cancer stem cells. Here, CD80 is linked to cancer.